صدى البلد البلد سبورت قناة صدى البلد صدى البلد جامعات صدى البلد عقارات
Supervisor Elham AbolFateh
Editor in Chief Mohamed Wadie
ads

British Scientist Warns: Coronavirus to Continue Forever


Mon 24 Aug 2020 | 08:36 PM
Ahmed Moamar

A prominent British scientist expected that the Coronavirus "COVID-19" will remain with the human race "forever in one way or another."

The scientist called for regular vaccinating of the population of the planet against the deadly disease.

The hopeless speculation was released by Sir Mark Walport, a member of the UK government's Emergency Scientific Advisory Group (SAGE).

COVID-19 is unlike some other diseases, such as smallpox "which can be eliminated by vaccination", the novel Coronavirus won't be completely eradicated.

Walport said in an interview with BBC Radio 4, believes that "global vaccination" becomes a must to contain the ongoing pandemic.

Walport explained that the deadly virus that will remain with us forever in one form or another, and it is almost certain that it will require repeated vaccinations, so, like influenza, people will need to be revaccinated at regular intervals.

Walport's comments came in response to a previous statement by the head of the World Health Organization, Tedros Adhanom Ghebreyesus, who expressed his hope that the pandemic would end in less than two years.

Ghebreyesus compared the "COVID-19" disease to the outbreak of the Spanish flu in 1918, indicating that the human race faced the Coronavirus in a more technological way.

At the same time, the world has become more open since the early twentieth century, facilitating the rapid spread of disease.

The latest figures released by Johns Hopkins University, USA, indicate that the global infections with the Coronavirus exceeded 23 million across the globe on Saturday.

The virus has been caused more than 800,000 deaths worldwide.

The United States, Brazil and India are still the countries most affected by the Coronavirus, accounting for nearly half of all cases in the world.

On the other hand, the chief expert at the World Health Organization (WHO), Somaya Swaminathan, said that the organization had started discussions with Russia and had requested safety and efficacy data for the Russian vaccine, "Sputnik-V", against Coronavirus.

Today Swaminathan confirmed that the trial of the third phase of the Russian vaccine will be the most important test.

She pointed out that the results of international experiments using blood plasma were not conclusive, and the evidence for their effectiveness is still very low.

For her part, the Director of the Health Programs Department at the WHO, Rana Al-Hujjah, said earlier that the organization is in contact with the Russian authorities to learn about the developments of the "Sputnik-V" vaccine.

According to information received from the Russian State Medicines Registry, the vaccine will be intramuscularly injected using two carriers in two batches: the first - with the first carrier, and after three weeks - with the second carrier.

The Russian Ministry of Health said that the dual injection system allows the building of long-lasting immunity for up to two years.

On the eleventh of this month, Russia announced the registration of the world's first vaccine against the Corona virus, and called it "Sputnik-V.

In an ongoing outbreak the final outcomes death or recovery for all cases is not yet known.

The time from symptom onset to death ranges from 2 to 8 weeks for COVID-19.  This means that some people who are currently infected with COVID-19 will die at a later date.

As we explain below, this needs to be kept in mind when comparing the current number of deaths with the current number of cases.

To understand the risks and respond appropriately the world must know the mortality risk of COVID-19 the likelihood that someone who catches the disease will die from it.

Scientists should look into this question in more detail further below in this article and explain that this requires us to know or estimate the number of total cases and the final number of deaths for a given infected population. Because these are not known, they discuss what the current data can and can not tell us about the risk of death .